Turnover-
EBIT margin-
Net result€24k-13.8%
Working capital€74k+51.1%
Conclusion
the dossier summarised in one paragraphThe computed 12-month bankruptcy probability of Izo2 is 0.3% (very low). The 2025 annual accounts show equity of €75k and a net result of €24k. Equity is growing by ~48.9% per year across the filed fiscal years. The company has been active since 2023 and the Belgian State Gazette contains no insolvency or warning signals.
Based on the State Gazette, CBE and 3 annual accounts.
Financials
FY 2025
€75k
equity
Turnover-
Net result€24kHealth93/100 · Excellent
See full annual accounts
People & board
No director data processed yet.
To directors Publications
No State Gazette publications linked.
To publications Network & structure
No network or structure data processed.
To structure
Trust signals
3 signalsMore than 3 years active
Founded in 2023, past the statistically most fragile first 3 years.
No legal incidents
No bankruptcy, reorganisation or interim measure in the Belgisch Staatsblad.
Administratively compliant
No FOD Economie strikeouts (UBO, accounts, address, activity).
Administrative Flags
0 events
No administrative flags
Bankruptcy probability (12 mo)
Checked model v1 · free for everyone0.3%
Very low
0%0,5%1,5%4%10%≥25%
Lower-failure-rate sector
−Young company
+Higher-failure-rate region
+
Statistical estimate based on public sources, not credit advice nor a finding of fact. How do we compute this?
Company registry (CBE)
Crossroads BankActivities
Ambulante revalidatieactiviteiten86905Activiteiten op het gebied van kinesitherapie86951
Primary activity highlighted.
Names & trade names
| Legal nameFR | Izo2 |
Registered office
Sperwerlaan 5
1150 Sint-Pieters-Woluwe, Belgium
Official data from the Crossroads Bank for Enterprises (CBE). Available for every registered company.